![Indranil Dey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Indranil Dey
Directeur Général chez BLUEJAY DIAGNOSTICS, INC.
Fortune : 123 539 $ au 31/05/2024
Profil
Indranil Dey is the founder of Bluejay Diagnostics, Inc. (founded in 2015) and Lana Management & Business Research International LLC (founded in 2007).
At Bluejay Diagnostics, Inc., he holds the titles of President, CEO, CFO, CAO & Director.
At Lana Management & Business Research International LLC, he held the title of Chief Operating Officer from 2008 to 2015.
Dr. Dey also has former job experience.
He worked as a Manager-Technology Licensing at Ciba-Geigy Corp.
and Thomas Jefferson University.
At IMPATH, Inc., he served as the Head-Western US Business Development from 2001 to 2005.
He was the Vice President-Business Development & Market at Definiens AG from 2005 to 2007.
Additionally, he worked as the Chief Business Officer at Genmethrax, Inc. In terms of education, Dr. Dey holds an MBA from the University of Cambridge.
He also completed his undergraduate and graduate degrees at Visva-Bharati University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
13/12/2023 | 233 093 ( 8,03% ) | 123 539 $ | 31/05/2024 |
Postes actifs de Indranil Dey
Sociétés | Poste | Début |
---|---|---|
BLUEJAY DIAGNOSTICS, INC. | Directeur Général | 01/01/2015 |
Anciens postes connus de Indranil Dey
Sociétés | Poste | Fin |
---|---|---|
Lana Management & Business Research International LLC | Fondateur | 01/01/2015 |
Definiens AG
![]() Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 01/01/2007 |
IMPATH, Inc. | Corporate Officer/Principal | 01/01/2005 |
Genmethrax, Inc. | Corporate Officer/Principal | - |
Ciba-Geigy Corp. | Corporate Officer/Principal | - |
Formation de Indranil Dey
University of Cambridge | Masters Business Admin |
Visva-Bharati University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BLUEJAY DIAGNOSTICS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Ciba-Geigy Corp. | Health Technology |
IMPATH, Inc. | Health Services |
Definiens AG
![]() Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Technology Services |
Lana Management & Business Research International LLC | |
Genmethrax, Inc. |